NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice

NCT07036718 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2026-04-13

No results posted yet for this study

Summary

This is a prospective, non-interventional, multicenter study to evaluate the efficacy and safety of iptacopan in patients with PNH in real-world settings in Russia.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-29
Primary Completion
2025-12-25
Completion
2025-12-25

Countries

  • Russia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07036718 on ClinicalTrials.gov